Earthquake may hit California, Washington, could sink Pacific Northwest region, claims study
A recent research study has warned that the next major earthquake in the Pacific Northwest region might end up sinking the coastal land by nearly seven feet. Northern parts of California and Oregon, along with southern Washington will be most hit, if the earthquake occurs, as per a report
#Pahalgam Terrorist Attack
Pakistan reopens Attari-Wagah border to allow stranded citizens in India to return
Key Jammu & Kashmir reservoirs' flushing to begin soon
Air India sees Pakistan airspace ban costing it $600 mn over 12 months
Those who will get to survive the tremor could face severe flooding in the area, The Washington Post reported, quoting that study that was published in the Proceedings of the National Academy of Sciences earlier this week.
Study decodes major risks to Pacific Northwest
A team of researchers from the
Virginia Tech University
has claimed that a magnitude 8.0 and greater tremor in the
Cascadia Subduction Zone
could result in a tsunami and severely impact the coastal communities.
The drastic rise in sea levels in the region would ultimately expand to as much as 115 square miles, it suggested.
According to Tina Dura, the lead author of the study, this means that there are possibilities of witnessing a disaster similar to the ones in Sumatra and Japan in 2004 and 2011, respectively.
Live Events
Dura and her team have found "the same kind of fault" as well as the capability to have a massive earthquake, followed by a tsunami and coastal subsidence. Over 227,000 deaths were reported after a 9.2 earthquake hit Sumatra on December 26, 2004, followed by tsunami in the region. On the other hand, the 9.1 earthquake in Japan's Tohoku left more than 18,000 dead in 2011, Independent reported.
Dura told The Washington Post that the sinking of land in the region would alter the coastal communities on a permanent basis. These communities already get to experience floods at the time of king tides.
Also Read :
Is Gen Z struggling with mental health and happiness? Harvard study uncovers alarming truths
When can this happen?
As of now, the researchers can't predict the exact time when the catastrophic quake might hit the region. The study noted that the last time when a powerful quake was reported in the Cascadia Subduction Zone was way back in 1700.
Dura claims that such major events usually are separated by about 450-500 years, adding that quakes can't be 'evenly spaced' at all times. She stated that "it could happen any day," before pointing out that there are chances that it might not take place anytime until 2100.
Further, the researchers highlight that the risk of floods due to a major earthquake in that year remains more than triple the risk that we have in today's times, taking into account the rise in sea levels.
Also Read :
Great white shark rescue: Father-son duo's heroic act, with help from locals, saves shark on Australian coast
FAQs
Q1. What is the Cascadia Subduction Zone?
A1. Stretching from Northern California to Vancouver Island in Canada, this is the region where one of the planet's crust dives beneath the other one.
Q2. Which regions can get affected by the earthquake?
A2. As per Independent, it can have major effects in the southern part of Washington as well as northern regions of Oregon and California.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
11 hours ago
- NDTV
Musk- Trump Feud Poses Serious Threat To NASA, Pentagon Programs: Report
New York: Elon Musk's threat, which he later retracted, to cut off NASA's use of SpaceX's Dragon spacecraft would be a huge blow to NASA, depriving the space agency of the only American vehicle capable of transporting astronauts to the International Space Station and dramatically changing how NASA would access the $100 billion orbiting laboratory, The Washington Post has reported. The threat, posted on X, came during an escalating fight between the wealthiest man in the world and President Donald Trump, after Trump had threatened to cancel all of Musk's company's federal contracts. "Given SpaceX's importance to multiple federal programs, severing those relationships could leave NASA as well as the Pentagon and intelligence agencies in a lurch," noted the report. Several hours after making the threat, Musk relented, saying in response to a post on X that he should cool off and reconsider: "Ok, we won't decommission Dragon." Over the years, SpaceX has become a vital contractor, launching sensitive national security payloads such as satellites that provide missile warning, battlefield communication and guide munitions to precise targets, Xinhua news agency reported. In a statement, Bethany Stevens, NASA's press secretary, did not address how NASA would continue to fly its astronauts to the ISS without SpaceX, writing only that "NASA will continue to execute upon the President's vision for the fulfillment of space. We will continue to work with our industry partners to ensure the President's objectives in space are met." Earlier Elon Musk called for the impeachment of US President Donald Trump and announced the decommissioning of the vital SpaceX programme after accusing that Trump's name is in the Epstein files, according to media reports. 'In light of the President's statement about cancellation of my government contracts, SpaceX will begin decommissioning its Dragon spacecraft immediately,' Musk said in a post on X.
News18
15 hours ago
- News18
Can This Covid Vaccine Technology Also 'Kick And Kill' HIV?
Last Updated: A team of Australian scientists has developed a novel method to reveal hidden HIV in white blood cells Scientists at Australia's Peter Doherty Institute for Infection and Immunity in Melbourne have developed a groundbreaking method to 'wake up" hidden HIV within the human body, a crucial step that could enable their complete removal. And they have used mRNA technology, the same kind used in Pfizer and Moderna's Covid-19 vaccines. Nearly 40 million people are living with HIV worldwide. One of the main challenges in curing the human immunodeficiency virus (HIV) lies in its ability to establish latent reservoirs. These are small numbers of infected cells, primarily resting CD4+ T cells, where the virus integrates its genome but remains dormant and invisible to both the immune system and antiretroviral therapies (ART). While ART can suppress the virus to undetectable levels, it cannot eliminate these hidden reservoirs. If treatment stops, the virus can re-emerge and replicate, necessitating lifelong medication for people living with HIV. The Australian team discovered a novel way to deliver 'special instructions" to these hidden, latently infected cells. In a study published in Nature Communications, the researchers demonstrated how they packaged mRNA inside novel, microscopic fat-like bubbles called lipid nanoparticles (LNPs), specifically a new design termed 'LNP X". The key breakthrough was engineering these LNPs to successfully transport the mRNA into the previously hard-to-reach resting CD4+ T cells. Once delivered, the mRNA instructs these cells to 'give up" the dormant virus, forcing it out of hiding and making it visible. This strategy aligns with the long-sought 'kick and kill" approach to HIV cure, where latency-reversing agents 'shock" the virus out of its dormant state, allowing the body's immune system or other therapies to 'kill" the newly exposed infected cells. Dr Paula Cevaal, a research fellow at the Doherty Institute and co-first author, described the initial results as astonishing, requiring repeated experiments to confirm their accuracy. 'We were overwhelmed by how big the difference was," she noted, emphasising the unprecedented success in revealing the hidden virus. While the research is currently laboratory-based and conducted on cells donated by HIV patients, this innovative method represents a significant step forward. The next crucial phase involves preclinical testing in animal models, followed by human trials to assess safety and efficacy. First Published: June 07, 2025, 04:36 IST
Hans India
a day ago
- Hans India
Scientists develop real-time genome sequencing to combat superbug
Australian scientists have made a breakthrough in combating Staphylococcus aureus, commonly known as golden staph - a superbug. The world-first initiative has demonstrated that real-time genome sequencing during severe infections allows doctors to quickly identify resistance mutations, and personalise treatment, Xinhua news agency reported. It will also help curb the spread of antibiotic resistance, said researchers from the Melbourne-based Peter Doherty Institute for Infection and Immunity (Doherty Institute). Collaborating with seven local hospitals, scientists from the Doherty Institute said that traditionally, hospital laboratories identify bacteria using standard tests that reveal only the species type, offering limited insight into antibiotic resistance or genetic changes. In contrast, genome sequencing provides a comprehensive genetic profile, uncovering mutations that can influence how bacteria respond to treatment. Previously, research into bacterial evolution was typically carried out retrospectively, often years after patients had completed treatment. In contrast, this new method enables clinicians to monitor bacterial changes in real-time, providing immediate and actionable insights for patient care, according to the study published in Nature Communications. Comparing golden staph samples from patients at the start of infection and at treatment failure, researchers found that in a third of cases, the bacteria developed mutations making standard antibiotics ineffective, said lead author Stefano Giulieri at the Doherty Institute and the University of Melbourne. 'In one case, after initially controlling a golden staph infection, the patient returned to the hospital two months after stopping antibiotics,' Giulieri said. Giulieri added that resistance increased 80-fold within two months, but genomic insights enabled clinicians to successfully adapt treatment and cure the infection. These findings represent a major step toward targeted therapy for bacterial infections and open the door to future clinical trials that could make this approach standard practice in hospitals worldwide, said the researchers.
